DYN
Dyne Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$17.92
-0.14 ▼ -0.78%
🌙 3월 13일 6:47 PM ET (한국 3/14 07:47)
$18.00
+0.08 ▲ +0.46%
| Index | RUT | P/E | - | EPS (ttm) | -3.54 | Insider Own | 27.21% | Shs Outstand | 0.16B | Perf Week | 20.59% |
| Market Cap | 2.96B | Forward P/E | - | EPS next Y | 5.41% | Insider Trans | -1.8% | Shs Float | 0.12B | Perf Month | 7.43% |
| Enterprise Value | 2.02B | PEG | - | EPS next Q | -0.77 | Inst Own | 91.35% | Short Float | 16.08% | Perf Quarter | -8.99% |
| Income | -0.45B | P/S | - | EPS this Y | 8.68% | Inst Trans | 15.38% | Short Ratio | 8.92 | Perf Half Y | 36.02% |
| Sales | 0.00B | P/B | 3.04 | EPS next 5Y | 16.36% | ROA | -47.52% | Short Interest | 19.32M | Perf YTD | -8.38% |
| Book/sh | 5.89 | P/C | 2.66 | EPS past 3/5Y | -2.41% 3.39% | ROE | -55.71% | 52W High | -28.32% ($25.00) | Perf Year | 50.84% |
| Cash/sh | 6.73 | P/FCF | - | Sales past 3/5Y | - | ROIC | -39.27% | 52W Low | 181.76% ($6.36) | Perf 3Y | 35.96% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -5.72% | Gross Margin | - | Volatility(W/M) | 11.82% 7.63% | Perf 5Y | 6.41% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 1.33 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 22.25 | EPS Q/Q | 13.34% | Profit Margin | - | RSI (14) | 55.15 | Recom | 1.31 |
| Dividend Gr. 3/5Y | - | Current Ratio | 22.25 | Sales Q/Q | - | SMA20 | 10.38% ($16.23) | Beta | 1.34 | Target Price | $38.19 |
| Payout | - | Debt/Eq | 0.17 | Earnings | 3000000 | SMA50 | 4.75% ($17.11) | Rel Volume | 1.13 | Prev Close | $18.06 |
| Employees | 258 | LT Debt/Eq | 0.17 | EPS/Sales Surpr. | 0.34% - | SMA200 | 17.1% ($15.3) | Avg Volume(3M) | 2.17M | Price | $17.92 |
| IPO | 2020/9/17 | Option/Short | Yes/Yes | Trades | 17890 | Volume | 2,445,234 | Change | -0.78% |
뉴스 로딩 중...